Cite
Stone AE, Scheuermann SE, Haile CN, et al. Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge. NPJ Vaccines. 2021;6(1):69doi: 10.1038/s41541-021-00329-0.
Stone, A. E., Scheuermann, S. E., Haile, C. N., Cuny, G. D., Velasquez, M. L., Linhuber, J. P., Duddupudi, A. L., Vigliaturo, J. R., Pravetoni, M., Kosten, T. A., Kosten, T. R., & Norton, E. B. (2021). Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge. NPJ vaccines, 6(1), 69. https://doi.org/10.1038/s41541-021-00329-0
Stone, Addison E, et al. "Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge." NPJ vaccines vol. 6,1 (2021): 69. doi: https://doi.org/10.1038/s41541-021-00329-0
Stone AE, Scheuermann SE, Haile CN, Cuny GD, Velasquez ML, Linhuber JP, Duddupudi AL, Vigliaturo JR, Pravetoni M, Kosten TA, Kosten TR, Norton EB. Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge. NPJ Vaccines. 2021 May 13;6(1):69. doi: 10.1038/s41541-021-00329-0. PMID: 33986280; PMCID: PMC8119695.
Copy
Download .nbib